Fridays vs Hims
Hims costs $50 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →If you are choosing between Fridays and Hims, the first difference is cost: Hims is $50 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hims leads our six-part score, 6.8 to 5.5. One of the two has an FDA warning letter on record, covered below.
Fridays vs Hims price
Hims is the cheaper way in: $199 a month against $249 a month at Fridays. That is $50 less each month (20% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Hims ($199 a month vs $249 a month); tirzepatide is cheaper at Hims ($299 a month vs $359 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
Fridays does not publish where it ships, and Hims lists 50 states.
Pricing
Fridays
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
What each price covers
Both prices cover the medication itself.
Fridays' price also covers the clinician visit and coaching, which Hims does not claim.
Fridays is silent on shipping and lab work.
Hims is silent on shipping and lab work.
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, Hims scores 6.8 and Fridays 5.5 out of 10.
Fridays is stronger on support (7.0 vs 3.0).
Hims is stronger on user experience (8.0 vs 3.0), trust & safety (7.0 vs 4.0) and accessibility (10.0 vs 5.0).
Value and effectiveness are within half a point.
Fridays
5.5/10
Hims
6.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Fridays has no FDA warning letter on record with us.
Features & Coverage
| Feature | Fridays | Hims |
|---|---|---|
| Starting Price | $249/mo | ✓$199/mo |
| Features | 2 features | 2 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →Pros & Cons
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hims wins this one, 6.8 to 5.5, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. It also costs $50 less each month than Fridays. Fridays fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Fridays vs Hims: FAQ
Close alternatives to Fridays and Hims
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
- Fridays vs Elevated Health
- Fridays vs Better U Care
- Hims vs Hers
- Hims vs Noom
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.